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Abstract 
Protein-protein interaction networks provide a global picture of cellular function and biological processes. 
Proteins interact largely through specific domains which constitute the main building blocks of an interaction 
network. Perturbed or dysfunctional protein interactions are linked to many diseases, including cancer.  
In this study we describe the major pathways and connections within the human cancer network by a novel 
approach in which we overlay the human cancer network with all protein interaction domain (PID) 
superfamilies. Based on 38,777 experimentally derived interactions, we constructed a cancer network with 8 
different levels and identified all major protein hubs within this cancer interactome. Only one percent of the 
cancer genes constitute over 50 percent of all interactions within the network.  
In addition, we mapped 56 PID superfamilies onto the cancer network, and discovered that over 10% of 
protein interaction domains are overrepresented within the cancer interactome when compared to the normal 
protein network. We present here a comprehensive list of all PIDs in the cancer network, identify the most 
important hubs within it and discover several individual genes which had previously not been linked to cancer. 
These proteins constitute excellent targets for the development of novel cancer therapeutics. Our results further 
hint to a partial molecular commonality between cancer and neurodegenerative diseases such as Alzheimer’s 
and Huntington’s.  
 
Keywords protein domain; interaction network; PDZ domain; systems biology; cancer; tumour; superfamily; 
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1 Introduction 
Cancer is a leading cause of death worldwide. The disease accounted for 7.4 million deaths (around 13% of all 
deaths worldwide) in 2007 and its associated mortality rate is expected to increase even further according to 
the World Health Organization.  Network Biology, 2011, 1(1):59-71 
 
 IAEES                                                                                                                                                                        www.iaees.org
Cancer is a heterogenous disease that can affect any part of the body. One of its defining feature is the rapid 
proliferation of abnormal cells that grow beyond their usual boundaries, invade adjoining parts of the body, 
and subsequently spread through blood and lymphatic vessels to form metastases in other organs which can 
lead to secondary tumours.  
Malignant tumours and neoplasms arise from one single cell in a multistage process, which typically 
involves progression from a pre-cancerous lesion to a malignant tumour. The changes leading to cancer are the 
result of the interaction between a person's genetic predisposition and external factors. In 2000, Hanahan and 
Weinberg defined six hallmarks of cancer (Hanahan and Weinberg, 2000): 1) self-sufficiency in growth 
signals, 2) insensitivity to antigrowth signals, 3) evasion of programmed cell death (apoptosis), 4) limitless 
replicative potential, 5) sustained angiogenesis and 6) tissue invasion and metastasis. Now, ten years later, it is 
becoming increasingly clear that tumour progression is even more complex and requires additional hallmarks, 
such as a shift in cellular metabolism (Tennant et al., 2009) as well as factors from the tumour 
microenvironment and from the tumour stroma interaction (Pietras and Ostman, 2010). 
All of these processes are ultimately linked and executed by the proteome and the road to malignancy is 
regulated by changes in protein activity, cellular protein composition and/or changes in protein interactions 
and in the protein network.  
The wealth of information gathered on cancer in general and on cancer related genes, including oncogenes 
and tumour suppressor genes, has thus far not transformed into a clear understanding of the molecular 
mechanisms and the exact cause underlying the formation of malignant tumours. A major challenge is to 
understand how pathological phenotypes arise from changes in the protein network or alterations in proteome 
connectivity in this complex multigene disease. In this study we compile and characterise the cellular cancer 
network and analyse its network of protein-protein interactions as one of the major driving forces of 
tumourigenesis.  
Within a complex network of interactions, a single molecule can affect a wide range of other cellular 
components (Chautard et al., 2009). Central to protein-protein networks or interactomes are modular protein 
interaction domains (PID), which organize them by promoting protein-protein binding. Within the network, 
adaptor proteins composed exclusively of PIDs mediate molecular interactions and link signaling proteins such 
as activated cell-surface receptors to downstream effectors thereby directing the flow of information (Pawson, 
2007). 
Protein-protein interaction (PPI) databases have become a major resource for investigating cellular protein 
networks and signaling pathways. A number of publicly available repositories for human PPIs are currently 
available and each of them has its own unique pattern and depth of annotations. 
According to the integration provided by the meta-database APID, the six major primary databases (BIND, 
BioGRID, DIP, HPRD, IntAct, and MINT), construct the largest known interactome with a total of 80,032 
interactions. The largest primary database that includes around 50% of the human PPIs (De Las Rivas and 
Fontanillo, 2010) is the Human Protein Reference Database (HPRD). It is a resource for experimentally 
derived information about the human proteome including protein–protein interactions, post-translational 
modiﬁcations (PTMs) and tissue expression data (Mathivanan et al., 2006; Keshava Prasad et al., 2009).  
The human interactome is defined as the entirety of interactions occuring in a human cell.  
The PPI data is sub-classified as binary (direct interactions between two proteins) or complex interactions 
based on topology and the number of participants. 
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In the present study we used the HPRD as the largest available list of experimentally derived human 
interactions to generate the human cancer interactome and performed a comparative analysis of the role of 
protein interaction domains in the human interactome versus the cancer network. 
 
2 Material and Methods 
2.1 Constructing and visualizing the human interactome 
The HPRD (8
th release) list of human binary protein-protein interactions in tab delimited format was obtained 
from the HPRD website. This list was loaded into the cytoscape software (version 2.6.3) to visualize the 
human interactome network.  
2.2 Generating the human cancer network 
A comprehensive list of cancer genes was obtained from the Wellcome Trust Sanger Institute website 
(http://www.sanger.ac.uk/). The cancer list contained 401 cancer genes, the Entrez ID and HUGO gene 
symbols of these were converted into the HPRD ID list format by using the converter at the Biomedical 
Information Research Center (BIRC) of the National Institute of Advanced Industrial Science and Technology  
(AIST) (http://biodb.jp/ids). After the conversion, 360 cancer gene IDs were found back in the human 
interactome, and their appropriate HPRD data were used to construct cancer networks on 8 different levels 
(examples of visualized networks are shown in Fig. 1). The first level cancer network was created from the 360 
cancer nodes. Only the direct interactions between the cancer genes were included in this network. The next 
level cancer network included the interactions of the cancer genes with their 1
st neighbours, but excluded 
neighbour-neighbour interactions. The third network was set to include the cancer nodes as well as their 1
st and 
2
nd neighbours. The edges in this network represent the interactions between the cancer genes themselves, 
between them and their 1
st or 2
nd neighbours and between 1
st and 2
nd neighbours, but not the interactions 
among 2
nd neighbours . The other levels of the network were constructed in the same way, and the maximum 
network size was obtained at the level of the 8
th neighbours. Due to the large size of the higher level cancer 
networks and their similarity to the general interactome, further analysis was restricted to the level of the 3
rd 
neighbour and below. Table 1 shows the connectivity of all constructed networks, and of the entire interactome. 
2.3 Investigation of Protein interaction domains (PID’s) 
Lists of all genes encoding the respective 56 PIDs from the Superfamily database 
(http://supfam.cs.bris.ac.uk/SUPERFAMILY/) (Gough et al., 2001)were prepared, annotated and batch 
converted using the Biomart online converter (www.biomart.org). Lists of domain encoding genes were 
converted to the HPRD ID format (http://biodb.jp/ids) in order to facilitate their investigation within the 
interactome. Proteins without matching HPRD IDs were not loaded into the network (Table 2). For each 
domain, the list of genes was loaded into the previously designed cancer networks as well as into the total 
human interactome network. Data from different networks including the number of nodes, edges, average 
interactions, as well as theoretical number of nodes and edges were calculated and the networks were analysed 
using the Cytoscape Network Analyser plugin (release 2.6.1) to calculate the average number of neighbours 
and the average node degree. 
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Fig. 1 Shown are different levels of the cancer network: (a) 3,068 nodes connected with 6,572 edges form the cancer network 
that include the cancer genes connected to their first neighbours. (b) The 360 cancer genes (nodes) connected by 695 edges, 
which forms the smallest network and includes only direct interactions and self-loops. Examples of Protein Interaction Domain 
(PID) networks are shown for the SH2 domain (in c and d) and for the WD40 domain (e and f). All figures were generated using 
Cytoscape.  
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Table 1 Shown are the numbers of nodes and edges found in the different interaction networks we constructed. The  
network representing the 360 cancer genes connected to their 1
st neighbours was used in the whole study and is referred  
to herein as the cancer network. 
Network  Nodes (% of Interactome)  Edges (% of Interactome) 
Human Interactome  9630 (100%)  38 777 (100%) 
Cancer nodes only  360 (3.73%)  695 (1.79%) 
Cancer+ 1st neighbours  3068 (31.85%)  6572 (16.95%) 
Cancer +2nd neighbours  7904 (82.07%)  31783 (81.96%) 
Cancer +3rd neighbours  9077 (94.25%)  38001 (98%) 
Cancer +4th neighbours  9202 (95.55%)  38382 (98.98%) 
Cancer +5th neighbours  9219 (95.73%)  38424 (99.09%) 
Cancer +6th neighbours  9224 (95.78%)  38431 (99.11%) 
Cancer +7th neighbours  9226 (95.8%)  38433 (99.11%) 
Cancer +8th neighbours 
(max.)  9227 (95.81%)  38435 (99.12%) 
 
 
 
Table 2 List of protein interaction domains (PID) and the number of proteins containing at least one  
of the corresponding domains (in brackets the number of proteins found back in the interactome after  
conversion to the respective HPRD IDs using Biomart) 
14-3-3  7 (7)  ENTH  27 (19)  PX  51 (32) 
ADF  17 (16)  F-BOX  47 (26)  RGS  38 (31) 
ANK  251 (115)  FERM  44 (27)  RIN
G 
309 (165) 
ARM  293 (185)  FF  4 (3)  SAM 109 (74) 
BAR  39 (25)  FHA  52 (40)  SH2  107 (99) 
BEACH 
 
8 (3)  FH2  22 (11)  SH3  205 (164) 
BH  13 (12)  FYVE  108 (64)  SPR
Y 
237 (115) 
BIR  9 (8)  GAT  8 (8)  TIR  21 (18) 
BRCT  23 (20)  GRIP  1 (1)  TPR  169 (100) 
BROMO  89 (30)  GYP  3 (3)  TRA
F 
24 (19) 
BTB-POZ 183 (87)  HECT  27 (21)  TSN
ARE 
15 (11) 
C1  58 (46)  LIM  123 (105)  TUB
BY 
5 (2) 
C2  153 (100)  MH1  8 (8)  TUD
OR 
52 (23) 
CH  74 (50)  NZF  4 (3)  UBA 35 (26) 
CHROMO  24 (18)  PAS  33 (23)  UEV 52 (39) 
DEATH  81 (65)  PB1  13 (12)  VHL 2 (2) 
DEP  199 (131)  PDZ  149 (123)  WD4
0 
256 (139) 
DH  70 (45)  PH  377 (255)  WW  42 (37) 
EF-hand  236 (145)  Polo-box  6 (4)     
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3 Results and Discussion 
3.1 Comparative analysis of protein-protein interaction networks 
Recent advances in proteomics and bioinformatics have made large datasets of experimentally derived protein-
protein interactions available and expanded the wealth of information on protein networks. The complete map 
of protein interactions that can occur in a living organism is called the interactome (Cusick et al., 2005).  
Recently, interactome mapping has become an important focus of biological and biomedical research (De 
Las Rivas and Fontanillo, 2010). In order to compare a large global protein interaction network to one 
restricted to cancer-related genes, we generated two different interaction networks with different levels, using 
the HPRD and a list of cancer genes from the Sanger Institute in Cambridge (www.sanger.ac.uk), respectively. 
A network representing 360 cancer genes from this list connected to their 1
st neighbours was used in the whole 
study and is referred to herein as the cancer network. 
We created our networks in cytoscape, an open source bioinformatics software platform, which enables 
comparative analysis and visualization of molecular interaction networks.(www.cytoscape.org) (Cline, Smoot 
et al., 2007). The human interactome we constructed included 9,630 nodes and 38,777 edges (and is from now 
on simply called the "interactome"). The human cancer networks produced from those genes listed in the 
HPRD that are also featured in the list of cancer genes available at the Sanger Institute website contains from 
360 (0
th  level) to 9077 (3
rd level) nodes and from 695 (0
th level) to 38 382 (3
rd level) edges (Fig. 1 and Table 1) 
The number of total interactions (edges) in the interactome is 5.9 times higher than the one in the 1
st level 
cancer network (Table 1). Similarly, 3.1 times more nodes are observed in the entire interactome than in the 
cancer network (Table 1). Almost a two-fold difference is observed in the ratio of nodes and edges, indicating 
that less nodes are necessary for the same number of intercations within the cancer network compared to the 
general interactome indicating higher connectivity in the cancer network than in the interactome. Recently, it 
was shown that cancer genes exhibit a network topology that is different from that of proteins not documented 
as being mutated in cancer with cancer proteins showing an increase in the number of proteins they interact 
with (Jonsson and Bates, 2006) and signaling domains were found more often in intermodular hub proteins 
associated with oncogenesis (Taylor et al., 2009). These findings are in accordance with our results on network 
topology. 
3.2 Investigation of the role of protein interaction domains (PID) in the interactome and in the cancer 
network  
Currently, 1,777 domain superfamilies are recognized in the latest release of the database Structural 
Classification of Proteins (SCOP) and of these less than 5% are protein interaction domains (Andreeva et al., 
2008). Despite this relative low abundance in the proteome and amongst the domain families, these PID’s 
naturally make major contributions to protein-protein interactions within protein networks. In order to asses 
each PID’s overall contribution to the interactome and to delineate its particular role in wiring the protein-
protein network, we generated a comprehensive list of all currently described PIDs within the 56 superfamilies 
defined in the SUPERFAMILY database (Gough et al., 2001) (Table 2). Genes coding for proteins with two 
different PIDs will appear in both respective superfamilies. For each of these PID superfamilies, a list of 
proteins containing the domain was generated from the database. The lists were then batch converted using 
Biomart converter and Ensemble ID’s, gene names and UnigeneID’s were extracted and finally converted to 
HPRD ID’s. Subsequently the HPRD IDs were used to construct the networks and analyse the different 
contribution of the PID’s to the entire interactome and the cancer network. Additionally, by loading the list of 
each PID containing protein in HPRD ID and attaching these proteins to their 1
st neighbours we could create 
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independent PID networks. The extracted PID networks were used to calculate the average number of 
interactions of the PIDs in the interactome by dividing the number of edges linked to all proteins containing 
this PID by the total number of proteins containing this PID. The average number of interactions for the mean 
of all 56 PID was determined to be 15.27 interactions/protein. We plotted the average interactions of individual 
PIDs against this mean which highlights (from a quantitative standpoint focusing solely on binding via the 
PIDs) the most important PIDs in the human interactome. It is important to note that other mechanisms of 
binding than via PIDs can contribute to the total protein interactions, these non-PID dependent interactions are 
obviously not accounted for in this analysis. Table 3 shows the individual fold changes compared to the mean 
for all PIDs. A total number of 6 PIDs showed a >1.5 fold elevated number of average interactions with two 
PIDs showing exceptionally high elevation (14-3-3 and MH1 domains with around 6.5 times the average of 
interactions of other PIDs per gene) (Table 3). It is noteworthy that the MH1 domain is also a well known 
protein/DNA binding domain and it is possible that DNA binding complexes contribute to these above average 
interactions of MH1 domains. Conversely, 26 PIDs showed less average interactions (again with a cut off of < 
1.5 fold) (Table 3). 
 
 
Table 3 Shown is the number of average interactions for each PID divided by the number of average interactions of all  
proteins in the interactome (=15.27). 
 
 
 
In a subsequent step we analysed the contribution of PIDs to the cancer network and further compared the 
numbers of interactions directly to our data obtained for the entire interactome. The cancer network includes 
360 cancer-related genes (these were genes with known HPRD IDs derived from the Sanger list of a total of 
401 cancer-related genes) and their 1
st neighbours. The 1
st level cancer network consists of 3068 nodes and 
6572 edges. Similar to our approach for the interactome, the average number of interactions per PID was 
calculated in the cancer network. In the 1
st level cancer network, the average number of interactions 
determined for the 56 PIDs was 6.7. Only 3 domains, the BEACH, GRIP and GYP domains, were completely 
65Network Biology, 2011, 1(1):59-71 
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absent from the cancer network a (did not have any nodes and were not correlated to either cancer genes 
directly or to their 1
st neighbours). Threfore these domains probably play no role for the cancer interactions. In 
the cancer network, the FH2, BROMO and MH1 domains had the highest average interactions with 6.8, 4.7 
and 4.6 times the average number of interactions of other PIDs, respectively (Table 3). The FH2 domain 
occurs in proteins regulating rearrangements of the actin cytoskeleton, which is a crucial process in cytokinesis 
and therefore of obvious relevance for the development and maintenance of cancer. Furthermore, f-actin 
rearrangements are of paramount importance in cell motility, which in turn is required for tumor tissue 
invasion and metastasis (Castrillon and Wasserman, 1994). BROMO domains mediate the recognition of 
acetylated histones and promote an open, transcriptionally active chromatin structure. Since tumor progression 
requires high transcription rates, the overrepresentation of BROMO domains in the cancer interaction network 
developped here is an expected result. Conversely, the CHROMO domain promotes the recognition of 
methylated chromatin and the formation of a closed, transcriptionally silent chromatin structure. Since this 
state is incompatible with tumor progression, an underrepresentation of the CHROMO domain is likewise 
expected. Other significant quantitative and qualitative differences were found between the interactome and 
the cancer network (see Fig. 3A and Table 4). In our comparison of the interactome to the cancer network, we  
 
Table 4 Shows the number of average interactions of each PID protein divided by the number of average interactions  
 of all proteins in the cancer network (=6.7). The Cut-offs were 1.5 fold (above green line) and 0.67 fold (below red line). 
 
 
 
divided the PIDs in four groups: 1) PIDs with a high number of average interactions in both normal 
(interactome) and the cancer network (12 PIDs); 2) PIDs with low average interactions in both normal and the 
cancer network (21 PIDs); 3) PIDs with low average interactions in the normal but high average interactions in 
the cancer network (6 PIDs) and 4) PIDs with high average interactions in normal but low interactions in the 
cancer network (10 PIDs). In total, 18 PIDs in (groups 1 and 3) have a higher number of interactions in the 
cancer network, while 31 PIDs (groups 2 and 4) have a lower number of interactions in the cancer network 
(Fig. 3 and Table 4). Our data shows (Fig.2) that there is a clear difference in the amount of interactions in the 
Protein interaction domain representation in the cancer network 
PID  Fold AI  PID  Fold AI  PID  Fold AI  PID  Fold AI 
FH2  6.87  BTB-POZ  1  DEP  0.5  CHROMO  0.35 
BROM
O  4.71  DH  0.91  SAM  0.49  PX  0.33 
MH1  4.61  LIM  0.91  PDZ  0.45  RGS  0.33 
VHL  2.99  ARM  0.86  Polo-box  0.45  WW  0.26 
FHA  2.3  PH  0.79  TUBBY  0.45  TPR  0.23 
BRCT  1.96  C2  0.77  TRAF  0.43  WD40  0.23 
SH2  1.8  EF-hand  0.76  BAR  0.42  HECT  0.22 
14-3-3  1.69  ANK  0.71  TUDOR  0.41  TIR  0.2 
BH  1.64  DEATH  0.7  FF  0.37  ADF  0.15 
PAS  1.37  BIR  0.7  UBA  0.37  NZF  0.15 
SH3  1.13  F-BOX  0.69  CH  0.36  TSNARE  0.14 
FERM  1.09  PB1  0.57  GAT  0.36     
C1  1.07  FYVE  0.54  UEV  0.36     
RING  1.06  ENTH  0.53  SPRY  0.35     
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interactome and the cancer network and the PIDs with the highest average interactions differ significantly 
between both networks. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Shown in alphabetical order are the average interactions for the total 56 PIDs in the interactome (grey bars) and the cancer 
network (white bars). The line in both graphs depicts the average number of interactions per PID per protein (15.71). 
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B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 (A) A heat map for the average interactions of PIDs in the ineractome and the cancer network shows the fold differences 
compared to the respective mean of all PIDs. Only 3 PIDs were not present in the cancer network (black) (B)The node degree 
distribution in the constructed interactome indicates a scale-free network. 
 
 
3.3 Analysis of network connectivity and identification of major cancer hubs 
In a network, a hub is a node with high connectivity. In accordance, in our interaction networks a hub is a 
protein with many interactions including self-binding (self-loops). To a certain extent it can be assumed that 
these hubs proteins play important roles in the interaction network. However, there is a balance between 
qualitative and quantitative contribution and their effects on respective functionality. Our plot of the node 
68Network Biology, 2011, 1(1):59-71 
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degree distribution for the interactome shows that the network is scale-free (Fig. 3B). By further investigating 
the hub sizes in both the interactome and the cancer network we identified the most connected proteins for 
both networks, which are thus involved in the majority of interactions. We determined all hub sizes and 
focused our analysis on the hubs of more than 5 to above 50 interactions and used different databases and a 
literature search to determine their known or unknown relation to cancer. In the cancer network we found that 
hubs with a node degree > 50 all represent very well-characterised proteins linked to cancer, including some 
major oncogenes (e.g. Raf)  and tumour suppressor genes (p53, Rb) (Fig.4 and Supplementary Material). By 
applying a filter to the interactome that maps the nodes according to their node degree, we found that nearly 
10% of the nodes (942 out of 9,630) are connected directly through around 70% of the interactions (27,734 out 
of 38,777). However when we applied the same filter to the cancer network, we found that only 3% of the 
nodes (87 out of 3,068) are connected to 70% of the interactions (4,583 out of 6,572). These 87 proteins 
represent the core interactors in the cancer network and 82 of them are found in the list of cancer genes 
maintained by the Sanger Institute. Not surprisingly, all 87 genes are well known for their relation to cancer. 
We assembled a comprehensive list of proteins at different node degrees (a summary is represented in (Table 5) 
and the complete list can be found in Supplementary Material. All genes (with node degrees of 5 or above) 
were searched for in the major databases GeneCards, Novoseek, OMIM and in the literature. The power of our 
approach to uncover yet unknown relationships of certain proteins to cancer is highlighted by the identification 
of the NMDA receptor type 1 among the interactors with node degrees between 5 and 10. While the gene of 
this protein had previously appeared to be completely unrelated to cancer, North et al. (North et al., 2010) very 
recently reported its expression in breast cancer cell lines Mcf-7 and SKBR3. Furthermore, the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Shown are the largest hubs in the cancer network (in red) connected with their direct interactors (1
st neighbours) (in blue). 
The node degree is mapped to node size. Major oncogenes (e.g. RAF, Harvey RAS and other oncogene products and tumor 
suppressors are identified including the EGFR, a receptor tyrosine kinase which signals via RAF-RAS to the MAPKinases in 
order to promote cell proliferation. EGFR is a major target for cancer therapies today. 
 
69Network Biology, 2011, 1(1):59-71 
 
 IAEES                                                                                                                                                                        www.iaees.org
presence of the NMDA receptor was shown to be necessary for the growth of human breast cancer xenografts 
in mice (North et al., 2010). That topological features of PPI networks and protein domain compositions are 
good predictors for cancer genes had recently been demonstrated (Li et al., 2009). We report here further the 
discovery of 5 proteins with node degrees between 5-10 which have not been linked to cancer before (TUB, 
TEC tyrosine kinase, TCF14, Presenilin1 and Huntingtin). In Figure 5 the direct interactions of all 5 genes are 
depicted. Two of these, Presenilin and Huntingtin, are important genes involved in the neurodegenerative 
diseases Alzheimer’s and Huntington’s, respectively. This suggests a partial underlying commonality in the 
wiring of these rather different diseases and cancer. The significance of these findings, especially in regard to 
functionality of these proteins requires further investigation. 
 
 
Table 5 Quantification of different hub sizes and the number of cancer genes present in different categories. 5 ND  
refers to hubs with 5-9 edges, 10 ND to 10-14, 15 ND to 15-19, 20 to 20-24, 25 to 25-49 and 50 to 50 and above edges. 
 
Fig. 5 Shown are the direct interactions of the 5 genes which we discovered here, which have more than 5 edges in the cancer 
network but have so far not been linked to cancer. In addition, we included the interactions of the NMDAR, a gene which we 
identified with above 5 interactions in our cancer network which just recently was linked to breast cancer by a single publication 
(North et al., 2010). 
 
 
 
Hubs present at different node degrees (ND) 
Number of Node Degree  5ND  10ND  15ND  20ND  25ND  50ND 
Number of Hubs  506  251  163  113  77  59 
Hubs not present in the cancer gene 
list of the Sanger institute  180 34  11  8  3  1 
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